In November, Independence updated several policies. Recently published updates include:
- 08.01.32f: Pegfilgrastim (Neulasta®) and related biosimilars. Notification date, 11/9/2021; Effective date, 2/7/2022.
- 08.01.73a: Filgrastim (Neupogen®) and related biosimilars, and tbo-filgrastim (Granix®). Effective date, 11/22/2021.
To learn more about our Medical and Claim Payment Policy portal, visit our resource page.
For important policy information related to COVID-19, visit the Commercial and Medicare Advantage News & Announcements sections of the portal.